1.
Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
2.
Response: Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
Response Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
Low risk of cervical cancer during a long period after negative screening in the Netherlands
Cost‐effectiveness of HPV‐based cervical screening based on first year results in the Netherlands: a modelling study
Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation m...